Fig. 4From: Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathwaysChanges in cell numbers and tumor survival rates under EGFRI treatment. a Changes in the number of various cells under EGFRI treatment. b Changes in the tumor cell survival rateBack to article page